Sulfonamide Intermediate Synthesis With Filtration-Based Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for synthesizing Mcl-1 inhibitors, such as compounds A1 and A2, suffer from low yield and purity, particularly in commercial production, and involve laborious purification steps like chromatography, leading to inefficiencies and impurities.
Innovation Solution
A novel synthetic process involving bromination and acetylation of (2S,3S)-butane-2,3-diol, followed by epoxidation, allylic addition, leaving group addition, nucleophilic substitution, and oxidation steps, to produce intermediates that are highly pure and can be directly processed without substantial purification, improving yield and purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If existing methods are used for synthesizing Mcl-1 inhibitors, then the synthesis process can be completed, but the yield and purity are low and laborious purification steps are required
Solution Approach 1:
The patent modifies reaction parameters including using specific reagents (NBS instead of traditional brominating agents), controlling reaction temperature (0-5°C for bromination), and selecting particular solvents (acetonitrile, dichloromethane) to optimize both purity and yield. The oxidation step uses controlled conditions with NaIO4 at 0-5°C to achieve high purity sulfonamide intermediates
Solution Approach 2:
The patent eliminates the need for chromatography purification by designing a synthesis route that produces intermediates with sufficient purity through careful reaction control. Impurities are removed through simple filtration and washing steps, extracting only the necessary purification actions while maintaining high yield
2Ease of manufacture
If existing methods are used for synthesizing Mcl-1 inhibitors, then the synthesis can proceed, but laborious purification steps like chromatography are required
Solution Approach 1:
The synthesis method is designed so that the reaction conditions themselves promote the formation of pure products. The bromination and oxidation steps are controlled to minimize byproduct formation, and the intermediates crystallize or can be filtered in high purity form, making the process self-purifying to a large extent
Solution Approach 2:
The patent removes the need for complex chromatography purification by designing a route where intermediates can be purified through simple filtration and washing. The synthesis pathway is structured to avoid difficult-to-remove impurities, extracting only the essential purification steps
3Reliability
If existing methods are used for synthesizing Mcl-1 inhibitors, then the process can be completed, but dimeric sulfur-based impurities are formed
Solution Approach 1:
The patent prevents dimeric sulfur-based impurity formation by controlling the oxidation conditions. The use of NaIO4 at controlled temperature (0-5°C) and the specific sequence of adding reagents prevents side reactions that would lead to dimer formation. The reaction conditions are designed in advance to counteract potential impurity formation
Solution Approach 2:
The patent changes key reaction parameters including oxidation potential, temperature, and reagent addition rate to prevent the formation of dimeric impurities. The controlled oxidation conditions ensure high product consistency and reliability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The new process achieves higher yields and improved chemical and chiral purity of intermediates, avoiding dimeric sulfur-based impurities and reducing the need for laborious purification methods, enabling efficient production at both small and large scales.
Implementation Method 1
admixing compound K, NBS, and an amine base to form compound L
Implementation Method 2
admixing compound N, a base and hydroxylamine-O-sulfonic acid to form compound Z
Implementation Method 3
oxidizing compound M to form compound N
Data Source
AI summary
Provided herein are processes for synthesizing Mcl-1 inhibitors and intermediates such as compound Z that can be used to prepare them. In particular, provided herein are processes for synthesizing compound A1, and salts or solvates thereof and compound A2, and salts and solvates thereof.


